Filing Details
- Accession Number:
- 0001209191-14-053574
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-19 19:34:42
- Reporting Period:
- 2014-08-18
- Filing Date:
- 2014-08-19
- Accepted Time:
- 2014-08-19 19:34:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1493566 | Otonomy Inc. | OTIC | Pharmaceutical Preparations (2834) | 262590070 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1410751 | Avalon Ventures Viii Lp | 1134 Kline Street La Jolla CA 92037 | No | No | Yes | No | |
| 1557058 | Avalon Ventures X, L.p. | 1134 Kline Street La Jolla CA 92037 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-18 | 740,057 | $0.00 | 748,589 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-08-18 | 660,580 | $0.00 | 1,409,169 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-08-18 | 91,011 | $8.79 | 1,500,180 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2014-08-18 | 50,001 | $16.00 | 1,450,179 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-08-18 | 705,598 | $0.00 | 705,598 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2014-08-18 | 109,375 | $16.00 | 814,973 | No | 4 | P | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2014-08-18 | 337,432 | $0.00 | 740,057 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2014-08-18 | 175,889 | $0.00 | 175,889 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2014-08-18 | 484,691 | $0.00 | 484,691 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2014-08-18 | 568,828 | $0.00 | 568,828 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2014-08-18 | 136,770 | $0.00 | 136,770 | $0.00 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series A Preferred Stock | Series A Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 6,432 | $0.00 | 6,432 | $31.09 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 14,106 | $0.00 | 14,106 | $14.18 |
| Series C Preferred Stock | Series C Preferred Stock Warrant (right to buy) | Disposition | 2014-08-18 | 91,011 | $0.00 | 91,011 | $8.79 |
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2014-08-18 | 91,011 | $0.00 | 91,011 | $8.79 |
| Common Stock | Common Stock Warrant (right to buy) | Disposition | 2014-08-18 | 91,011 | $0.00 | 91,011 | $8.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | 2018-11-04 | No | 4 | C | Direct | |
| 14,106 | 2018-11-04 | No | 4 | C | Direct | |
| 0 | 2018-12-08 | No | 4 | C | Direct | |
| 14,106 | 2018-12-08 | No | 4 | C | Direct | |
| 0 | 2019-01-14 | No | 4 | C | Direct | |
| 14,106 | 2019-01-14 | No | 4 | C | Direct | |
| 0 | 2019-04-13 | No | 4 | C | Direct | |
| 14,106 | 2019-04-13 | No | 4 | C | Direct | |
| 0 | 2019-07-01 | No | 4 | C | Direct | |
| 14,106 | 2019-07-01 | No | 4 | C | Direct | |
| 0 | 2019-10-08 | No | 4 | C | Direct | |
| 14,106 | 2019-10-08 | No | 4 | C | Direct | |
| 0 | 2019-12-15 | No | 4 | C | Direct | |
| 14,106 | 2019-12-15 | No | 4 | C | Direct | |
| 0 | 2020-01-22 | No | 4 | C | Direct | |
| 14,106 | 2020-01-22 | No | 4 | C | Direct | |
| 0 | 2020-04-01 | No | 4 | C | Direct | |
| 14,106 | 2020-04-01 | No | 4 | C | Direct | |
| 0 | 2020-05-28 | No | 4 | C | Direct | |
| 14,106 | 2020-05-28 | No | 4 | C | Direct | |
| 0 | 2014-08-18 | No | 4 | C | Direct | |
| 91,011 | 2014-08-18 | No | 4 | C | Direct | |
| 0 | 2014-08-18 | No | 4 | X | Direct |
Footnotes
- Avalon Ventures VIII GP, LLC ("Avalon VIII GP"), the general partner of Avalon Ventures VIII, L.P. ("Avalon VIII LP"), has sole voting and dispositive power with respect to the securities held by Avalon VIII LP. Kevin Kinsella, Stephen Tomlin, Richard Levandov, Braden Bohrmann, Douglas Downs and Jay Lichter, one of our directors, are the managing directors of Avalon VIII GP. Such persons and entities disclaim beneficial ownership of the securities held by Avalon VIII LP except to the extenet of any pecuniary interest therein.
- The Series A Convertible Preferred Stock automatically converted into Common Stock on a 2.193204365 to one basis immediately prior to the completion of the Issuer's initial public offering of common stock and had no expiration date.
- Each of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of common stock and had no expiration date.
- The reported securities are held of record by Avalon Ventures X, L.P. ("Avalon X LP"). Avalon Ventures X GP, LLC ("Avalon X GP"), the general partner of Avalon X LP, has sole voting and dispositive power with respect to the securities held by Avalon X LP. Kevin Kinsella, Stephen Tomlin, Richard Levandov, Braden Bohrmann, Douglas Downs and Jay Lichter, one of our directors, are the managing directors of Avalon X GP. Such persons and entities disclaim beneficial ownership of the securities held by Avalon X LP except to the extenet of any pecuniary interest therein.
- The warrants are immediately exercisable.
- The Series C Preferred Stock Warrants automatically converted into Common Stock Warrants on a one to one basis immediately prior to the completion of the Issuer's initial public offering of common stock.
- Avalon VIII LP exercised the warrants to purchase 91,011 shares of Issuer Common Stock for $8.79 per share immediately prior to the completion of the Issuer's initial public offering of common stock. Avalon VIII LP paid the exercise price on a cashless basis, resulting in Issuer's withholding of 50,001 of the warrant shares to pay the exercise price and issuing to Avalon VIII LP the remaining 41,010 shares. The shares issued pursuant to such exercise remain subject to a 180-day lock-up restriction.
- Avalon X LP purchased 109,375 shares of Issuer Common Stock in the Issuer's initial public offering.
Billionaire Hedge Funds
